Thermo Fisher Scientific Forms Consortium to Drive Immunotherapy Research Across EuropeMarkets InsiderAMSTERDAM and MADRID and CARLSBAD, California, Aug. 31, 2017 /PRNewswire/ — Thermo Fisher Scientific has formed the Immuno-Oncology Consortium to dri… Continue reading
|
Breakthrough gene therapy cleared for childhood leukemia
Youngstown Vindicator The Food and Drug Administration called the approval historic, the first gene therapy to hit the U.S. market. Made from scratch for every patient, it’s one of a wave of “living drugs” under development to fight additional blood cancers and other tumors … |
MIT Technology Review |
In a Sign of Gene-Editing Frenzy, Startup Pitches Editing without CRISPR
MIT Technology Review So far, CRISPR is the most versatile gene-editing system known. To edit a genome, it relies on a nuclease—a protein enzyme that slices through the DNA double helix. That damage sets off emergency repairs inside a cell that scientists can harness to … Experts explain the ‘CRISPR‘ practice: A controversial gene editing technologyThe Daily Orange |
|
FDA Oks Genentech’ Actemra To Treat CAR T Cell-Induced Cytokine Release Syndrome
Markets Insider (RTTNews) – Genentech, a member of the Roche Group (RHHBY), announced that the U.S. Food and Drug Administration has approved Actemra (tocilizumab) intravenous injection for the treatment of chimeric antigen receptor (CAR) T cell-induced severe or … |
ABC Online |
Leukaemia breakthrough CAR–T uses children’s own blood cells to attack cancer
ABC Online A breakthrough treatment that genetically engineers patients’ own blood cells into an army of assassins to destroy childhood leukemia has been approved by US officials, opening a new era in cancer care. |
Q13 FOX |
US clears breakthrough gene therapy for childhood leukemia
Q13 FOX “This is a brand new way of treating cancer,” said Dr. Stephan Grupp of Children’s Hospital of Philadelphia, who treated the first child with CAR–T cell therapy — a girl who’d been near death but now is cancer-free for five years and counting. “That’s … |